Literature DB >> 9405202

Yeast as a model system to study drugs effective against apicomplexan proteins.

C H Sibley1, V H Brophy, S Cheesman, K L Hamilton, E G Hankins, J M Wooden, B Kilbey.   

Abstract

Biochemical and genetic analyses are required to identify potential drug targets in apicomplexan parasites, but these studies have proved difficult in most parasite systems. We have developed methods based on expression of parasite proteins in the budding yeast, Saccharomyces cerevisiae, to rapidly screen drugs directed against particular parasite targets, to study the structure and function of these target molecules, and to identify mutations in the parasite genes that alter enzyme specificity or drug sensitivity. In this paper we outline the parameters that need to be considered to design yeast strains that function efficiently to assay function of parasite proteins. Basic protocols and methods are included. We detail some problems that might be encountered in the engineering of these yeast strains and suggest possible solutions. Copyright 1997 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9405202     DOI: 10.1006/meth.1997.0511

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  13 in total

1.  System for expression of microsporidian methionine amino peptidase type 2 (MetAP2) in the yeast Saccharomyces cerevisiae.

Authors:  Rajendra Upadhya; Hong Shan Zhang; Louis M Weiss
Journal:  Antimicrob Agents Chemother       Date:  2006-08-17       Impact factor: 5.191

2.  Compensatory mutations restore fitness during the evolution of dihydrofolate reductase.

Authors:  Kyle M Brown; Marna S Costanzo; Wenxin Xu; Scott Roy; Elena R Lozovsky; Daniel L Hartl
Journal:  Mol Biol Evol       Date:  2010-06-24       Impact factor: 16.240

3.  Novel Saccharomyces cerevisiae screen identifies WR99210 analogues that inhibit Mycobacterium tuberculosis dihydrofolate reductase.

Authors:  A'Lissa B Gerum; Jonathan E Ulmer; David P Jacobus; Norman P Jensen; David R Sherman; Carol Hopkins Sibley
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

4.  A densely overlapping gene fragmentation approach improves yeast two-hybrid screens for Plasmodium falciparum proteins.

Authors:  Hakeenah F Brown; Ling Wang; Sudip Khadka; Stanley Fields; Douglas J LaCount
Journal:  Mol Biochem Parasitol       Date:  2011-04-20       Impact factor: 1.759

5.  Identification of Cryptosporidium parvum dihydrofolate reductase inhibitors by complementation in Saccharomyces cerevisiae.

Authors:  V H Brophy; J Vasquez; R G Nelson; J R Forney; A Rosowsky; C H Sibley
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

6.  2,4-diaminopteridine-based compounds as precursors for de novo synthesis of antifolates: a novel class of antimalarials.

Authors:  Eunice Nduati; Sonya Hunt; Eddy M Kamau; Alexis Nzila
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

7.  Efficacies of lipophilic inhibitors of dihydrofolate reductase against parasitic protozoa.

Authors:  H Lau; J T Ferlan; V H Brophy; A Rosowsky; C H Sibley
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

8.  Development of a yeast assay for rapid screening of inhibitors of human-derived Pneumocystis carinii dihydrofolate reductase.

Authors:  Liang Ma; Qiuyao Jia; Joseph A Kovacs
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

9.  Dihydropteroate synthase mutations in Pneumocystis jiroveci can affect sulfamethoxazole resistance in a Saccharomyces cerevisiae model.

Authors:  Peter Iliades; Steven R Meshnick; Ian G Macreadie
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

10.  Pyrimethamine and WR99210 exert opposing selection on dihydrofolate reductase from Plasmodium vivax.

Authors:  Michele D Hastings; Carol Hopkins Sibley
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.